Evoke Wealth’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $695K | Buy |
6,470
+2,632
| +69% | +$283K | 0.02% | 269 |
|
|
2025
Q1 | $387K | Buy |
3,838
+297
| +8% | +$30K | 0.01% | 307 |
|
|
2024
Q4 | $316K | Buy |
3,541
+738
| +26% | +$65.9K | 0.01% | 334 |
|
|
2024
Q3 | $235K | Buy |
+2,803
| New | +$235K | 0.01% | 372 |
|
|
2022
Q4 | – | Sell |
-1,091
| Closed | -$42K | – | 475 |
|
|
2022
Q3 | $42K | Buy |
1,091
+86
| +9% | +$3.31K | ﹤0.01% | 541 |
|
|
2022
Q2 | $37K | Buy |
1,005
+34
| +4% | +$1.25K | ﹤0.01% | 555 |
|
|
2022
Q1 | $43K | Buy |
971
+115
| +13% | +$5.09K | ﹤0.01% | 544 |
|
|
2021
Q4 | $36K | Hold |
856
| – | – | ﹤0.01% | 575 |
|
|
2021
Q3 | $37K | Hold |
856
| – | – | ﹤0.01% | 548 |
|
|
2021
Q2 | $37K | Sell |
856
-136
| -14% | -$5.88K | ﹤0.01% | 558 |
|
|
2021
Q1 | $38K | Buy |
992
+132
| +15% | +$5.06K | ﹤0.01% | 484 |
|
|
2020
Q4 | $31K | Hold |
860
| – | – | ﹤0.01% | 435 |
|
|
2020
Q3 | $33K | Hold |
860
| – | – | ﹤0.01% | 410 |
|
|
2020
Q2 | $30K | Sell |
860
-5
| -0.6% | -$174 | ﹤0.01% | 411 |
|
|
2020
Q1 | $28.2K | Sell |
865
-276
| -24% | -$9.01K | ﹤0.01% | 392 |
|
|
2019
Q4 | $51.6K | Sell |
1,141
-13
| -1% | -$588 | 0.01% | 402 |
|
|
2019
Q3 | $47K | Buy |
+1,154
| New | +$47K | 0.01% | 478 |
|